Rellim Capital Management has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Orbital Therapeutics's $270M Series A round in April 2023, alongside Redmile Group, Newpath Management, Moore Strategic Ventures and 6 others. That company is in Health and bio.

What Rellim Capital Management invests in

• Health and bio · 1 · 100%
• Data and analytics · 1 · 100%
• Logistics and mobility · 1 · 100%

How Rellim Capital Management invests

Share is of the 1 round on Recent Funding that name Rellim Capital Management. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Rellim Capital Management portfolio companies

• OOrbital Therapeutics$270MSeries A · Apr 2023

Most frequent co-investors

• MMoore Strategic Ventures1 shared round · last Apr 26, 2023
• AARCH Venture Partners1 shared round · last Apr 26, 2023
• IInvus1 shared round · last Apr 26, 2023
• CCasdin Capital1 shared round · last Apr 26, 2023
• IiGlobe Partners1 shared round · last Apr 26, 2023
• EEXOR N.V.1 shared round · last Apr 26, 2023
• RRedmile Group1 shared round · last Apr 26, 2023
• NNewpath Management1 shared round · last Apr 26, 2023
• HHeritage Medical Systems1 shared round · last Apr 26, 2023

Similar investors

• 221501 company · 1 deal in 12 mo
• CCove Hill Partners1 company · 1 deal in 12 mo
• DDSW Ventures1 company · 1 deal in 12 mo
• NNorth Bridge Venture Partners & Growth Equity1 company
• CCastrum Capital2 companies · 2 deals in 12 mo
• SSelah Ventures2 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Rellim Capital Management, which is a subset of its real portfolio. API: /api/v1/investors/rellim-capital-management (get a free API key). More: the most active VC firms and new venture capital funds.